Organic Active Ingredients TRIZ Cases

Optimized dosing regimens activate the STING pathway to induce anti-tumor effects while minimizing inflammatory cytokine levels.

Electroporation devices regulate intraocular pressure by targeting the trabecular meshwork, avoiding side effects from traditional eye drops.

Nanoprecipitation creates stable lipid nanoparticles to protect nucleic acids from degradation and enhance intracellular delivery efficiency.

Intrauterine drug administration normalizes gene expression patterns to alleviate endometriosis symptoms.

Fostemsavir induces gp160 conformational changes that improve antibody recognition, resolving viral evasion mechanisms.

Extracellular antibodies bind M(H)DM2/4 to block p53 regulation and prevent metastasis.

An intron interrupts toxic gene sequences to enable high-titer viral vector production in insect cells.

Aerosolized TLR agonists modulate immune responses, reducing IgE and eosinophils to address underlying inflammatory progression in asthma.

14-3-3β and 14-3-3γ proteins modulate PPARγ2 transcriptional activity to treat non-alcoholic fatty liver disease.

Nested helical windings maintain tubular shape while resolving the trade-off between radial strength and vessel trauma.

Crystalline free acid form of an EP4 antagonist improves chemical and physical stability while maintaining pharmaceutical efficacy.

Macrocyclic pyrrolopyrimidines inhibit polo-like kinase 4 through localized structural interactions.

Combining leucine with omega-3 fatty acids regulates blood plasma calcium levels.

L-Carnitine tartrate and fumaric acid dry admixture corrects genetic mutations by promoting mitochondrial repair.

Type I inhibitors bind active FLT3 conformations to overcome clinical resistance from F691L and D835Y mutations.

Basic pH heating doubles polyphenol yield from citrus peels, resolving low extraction efficiency and purity constraints.

Anionic surfactants adhere to silicone vesicles, preventing turbidity from high medicinal agent concentrations.

Hydroxy aliphatic substituted phenyl aminoalkyl ether compounds increase ERK and Akt kinase phosphorylation to enhance neuroplasticity.

Viscous suspending vehicles in chewable lozenges adhere to esophageal mucosa, reducing inflammation without systemic toxicity.

Treating pluripotent cells with GSK-3B inhibitors expands cell populations and drives differentiation into definitive endoderm lineages.

3-phenoxy-azetidine derivatives selectively elevate frontal cortex catecholamines, reducing systemic side effects.

Anti-CD48 antibody-drug conjugates deliver Mcl-1 inhibitors to tumor cells, overcoming drug resistance and sparing normal tissue.

Transparent chitosan gel controls bleeding without scarring or obscuring the surgical field, resolving trade-offs between hemostasis and access.

Amphiphilic liquid crystalline brush block copolymers self-assemble into nanoparticles with a hydrophobic core and hydrophilic shell.

Administers a single pre-exposure dose of tenofovir and emtricitabine to prevent self-replicating infection before viral establishment.

Segmented nucleotide prodrugs enhance oral bioavailability and targeted delivery to hepatocytes.

CD38 inhibitors block enzyme activity to elevate tissue NAD+ concentrations, treating metabolic disorders driven by cellular depletion.

Bidens pilosa extract lowers fat accumulation without suppressing food intake, addressing obesity treatment side effects.

A tamper-resistant tablet uses a matrix material holding particulates containing active compounds and polyalkylene oxide.

Administers 2,2′-anhydropyrimidine alongside uridine modulators to prevent chemotherapy-induced mucositis severity.

A 25-hydroxy vitamin D3 complex with beta-cyclodextrin improves water solubility and bioavailability.

Reduced nicotinamide riboside boosts NAD+ biosynthesis to treat acute and chronic kidney injury.

EP4 agonist compounds lower intraocular pressure by facilitating aqueous humor drainage, addressing limitations of beta-blockers in secondary glaucoma.

Substituted tetrahydro-4H-indol-4-one compounds inhibit Bub1 kinase to disrupt mitotic checkpoints.

Methanol-toluene solubilization isolates long-chain fatty acids from Tabebuia impetiginosa bark, resolving low purity in conventional extraction.

Redox-responsive cationic copolymers complex with nucleic acids to enable endosomal escape and intracellular release.

Covalent inhibitors form stable bonds with DCN1 Cys 115, resolving low affinity issues in non-covalent designs and boosting potency.

A lipid-based pre-formulation releases bioactive agents via phase transition, eliminating burst release and irritation.

Liquid capsule compositions form in situ matrices upon digestive contact, resolving inconsistent release caused by pH and enzyme variations.

Ketone-based crystallization of Raltegravir potassium Form 3 eliminates polymorph contamination and reduces solvent waste through precise parameter control.

Polyphenol nanocomplexes adhere diverse biomolecules to mammalian cells, preventing denaturation and damage during functionalization.

Bacillus aryabhattai converts colchicine into glycosylated derivatives, reducing hazardous reagent use and raw material loss.